Skip to content

Total Equity at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$7.37B+6.3%
NeoGenomics logo
NeoGenomicsNEO
$828.76M-6.7%
Illumina logo
IlluminaILMN
$2.68B+13.0%
Veracyte logo
VeracyteVCYT
$1.34B+12.5%
Guardant Health logo
Guardant HealthGH
-$181.07M+27.8%
Natera, Inc. logo
Natera, Inc.NTRA
$1.77B+43.1%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s total equity?
Personalis, Inc. (PSNL) reported total equity of $254.77M in Q1 2026.
How has Personalis, Inc.'s total equity changed year-over-year?
Personalis, Inc.'s total equity increased by 22.9% year-over-year, from $207.35M to $254.77M.
What is the long-term trend for Personalis, Inc.'s total equity?
Over 5 years (2020 to 2025), Personalis, Inc.'s total equity has grown at a 6.0% compound annual growth rate (CAGR), from $194.95M to $261.19M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.